Among patients with coronavirus disease (COVID-19), IgM levels increased early after symptom onset for those with mild and severe disease, but IgG levels increased early only in those with severe disease. A similar pattern was observed in a separate serosurveillance cohort. Mild COVID-19 should be investigated separately from severe COVID-19.2020R01 AG054046/AG/NIA NIH HHS/United StatesT32 HL116271/HL/NHLBI NIH HHS/United States32857691PMC7706962877
The purpose of this study is to monitor specific anti-severe acute respiratory syndrome coronavirus ...
The kinetics of IgG antibodies after coronavirus disease 2019 (COVID-19) remain poorly understood. W...
Viral and host immune kinetics during acute COVID-19 and after remission of acute symptoms need bett...
Aim: To examine the symptomatic estimation of serological testing also dynamic difference of serum n...
ABSTRACTSerum levels of IgG, IgM and IgA against severe acute respiratory distress syndrome (SARS)-a...
Background: Coronavirus disease 2019 (COVID-19) has spread rapidly in China and globally. In order t...
Serum levels of IgG, IgM and IgA against severe acute respiratory distress syndrome (SARS)-associate...
We determined the kinetics of anti-SARS-CoV-2 antibody response in fifteen hospitalized COVID-19 pat...
Association of COVID-19 IgG, IgM, and IgA among COVID-19 patients with demographic and clinical data...
The present study was planned to estimate some parameters linked covid 19 in Iraqi patients and thes...
International audienceHumoral immunity is critically important to control COVID-19. Long-term antibo...
Objective: The aim of this study was to evaluate the seropositivity of rapid immunoglobulin G (IgG) ...
The factors affecting the dynamics of lengthening of symptoms and serologic responses are not well k...
BACKGROUND Severe coronavirus disease 2019 (COVID-19) frequently entails complications that bear ...
COVID-19 is associated with a wide spectrum of disease severity, ranging from asymptomatic to acute ...
The purpose of this study is to monitor specific anti-severe acute respiratory syndrome coronavirus ...
The kinetics of IgG antibodies after coronavirus disease 2019 (COVID-19) remain poorly understood. W...
Viral and host immune kinetics during acute COVID-19 and after remission of acute symptoms need bett...
Aim: To examine the symptomatic estimation of serological testing also dynamic difference of serum n...
ABSTRACTSerum levels of IgG, IgM and IgA against severe acute respiratory distress syndrome (SARS)-a...
Background: Coronavirus disease 2019 (COVID-19) has spread rapidly in China and globally. In order t...
Serum levels of IgG, IgM and IgA against severe acute respiratory distress syndrome (SARS)-associate...
We determined the kinetics of anti-SARS-CoV-2 antibody response in fifteen hospitalized COVID-19 pat...
Association of COVID-19 IgG, IgM, and IgA among COVID-19 patients with demographic and clinical data...
The present study was planned to estimate some parameters linked covid 19 in Iraqi patients and thes...
International audienceHumoral immunity is critically important to control COVID-19. Long-term antibo...
Objective: The aim of this study was to evaluate the seropositivity of rapid immunoglobulin G (IgG) ...
The factors affecting the dynamics of lengthening of symptoms and serologic responses are not well k...
BACKGROUND Severe coronavirus disease 2019 (COVID-19) frequently entails complications that bear ...
COVID-19 is associated with a wide spectrum of disease severity, ranging from asymptomatic to acute ...
The purpose of this study is to monitor specific anti-severe acute respiratory syndrome coronavirus ...
The kinetics of IgG antibodies after coronavirus disease 2019 (COVID-19) remain poorly understood. W...
Viral and host immune kinetics during acute COVID-19 and after remission of acute symptoms need bett...